Microsatellite-stable (MSS) colorectal cancer (CRC) is generally regarded as the cold tumor with poor immunogenicity and scare immune cell infiltration, which is unlikely to benefit from anti-PD-1/PD-L1 (131). The gene discussed is PDCD1; the disease is neoplasm.